Michael D. Clayman, President and CEO at Flexion Therapeutics Inc (FLXN), bought 2,317 shares at $10.85 ($25K) on 2019-08-08, disclosed to the SEC on 2019-08-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| FLXN | BUY | 2019-03-13 | $100K | — | Filing → |
| FLXN | SELL | 2019-01-04 | $41K | — | Filing → |
| FLXN | BUY | 2018-11-13 | $86K | — | Filing → |